Back to results
CompletedPhase 2

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

NCT03507790

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

21st Century Neurology/ Xenoscience Inc.

Phoenix, Arizona, United States

+31 additional locations

View on ClinicalTrials.gov
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. — TrialFind